CEACAM-8

CEACAM-8

CEACAM-8 Molekülinformation

Molecule Name
Non specific cross-reacting antigen 95
Molekülalias
CEACAM8,CD66b,CD67,CGM6,NCA-95
Drug Development Progress
Anzahl der klinischen Arzneimittel1
Anzahl der inverkehr gebrachten Arzneimittel1
Höchste Forschungs- und EntwicklungsphaseApproved
Target-Alias
Non-specific cross-reacting antigen NCA-95,CGM6,Carcinoembryonic Antigen Gene Family Member 6,CD66b Antigen,NCA-95,CD67,Carcinoembryonic antigen CGM6,CD66b,CEACAM8,Carcinoembryonic Antigen Related Cell Adhesion Molecule 8,Carcinoembryonic Antigen-Related Cell Adhesion Molecule 8,CD67 Antigen,CEA Cell Adhesion Molecule 8
Molekülhintergrund
Carcinoembryonic antigen-related cell adhesion molecule 8 (CEACAM8) is also known as CD66b (Cluster of Differentiation 66b), CD66b, CD67, CGM6, NCA-95, and is one of seven human CEACAM family members within the immunoglobulin superfamily. CEACAM family members are a set of widely expressed proteins involved in several biological functions, including cell adhesion, migration, signal transduction, and the regulation of gene expression. Abnormal overexpression and downregulation of some CEACAMs have been described in tumor cells. In humans, CEACAMs include type I transmembrane proteins (CEACAM1, CEACAM3, and CEACAM4) and GPI-linked molecules (CEACAM5 through CEACAM8). There is no human CEACAM2. CEACAM8 is a single chain, two Ig-like C2-type (immunoglobulin-like) domains and one Ig-like V-type (immunoglobulin-like) domain. It is an activation marker for human granulocytes.

CEACAM-8 Produktliste

Species
  • Human(2)
Tag
  • His Tag(1)
  • His Tag & Avi Tag(1)
Host
  • HEK293(2)
Conjugate
  • Biotin-labeled(1)
  • Unconjugated(1)
Grade
  • RUO(2)
Low Endotoxin
  • Yes(1)
  • No(1)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
CEACAM-8
Human CEACAM-8 / CD66b Protein, His Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$390.00

100ug
CEACAM-8
Avitag
CE8-H82E9
Biotinylated Human CEACAM-8 / CD66b Protein, His,Avitag™ (SPR verified)
Human
HEK293
SDS-PAGE
ELISASPR

$360.00

25ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
90Y-DTPA-besilesomabTLX-66Phase 2 ClinicalTelix Pharmaceuticals Ltd
Multiple Myeloma; Neoplasms, Plasma Cell; Plasmacytoma
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Besilesomab99Tcm-BW250-183; TLX-66-CDx; TLX66-CDx; BW-250-183ApprovedCis Bio International SaScintimunEUOsteomyelitisCis Bio International Sa2010-01-11
Osteomyelitis
Details
Customer Reviews